The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PET-directed local or systemic therapy intensification in prostate cancer patients with post-prostatectomy biochemical recurrence: A trial of the ECOG-ACRIN Cancer Research Group (EA8191).
 
Neha Vapiwala
Consulting or Advisory Role - Magellan Health
 
Yu-Hui Chen
Employment - Constellation Pharmaceuticals (I); Flagship VL59 (I)
Stock and Other Ownership Interests - Constellation Pharmaceuticals (I)
 
Steve Y. Cho
Consulting or Advisory Role - Blue Earth Diagnostics; Focus-X Therapeutics; Progenics
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst)
Other Relationship - Radmetrix
 
Fenghai Duan
No Relationships to Disclose
 
Christos Kyriakopoulos
Consulting or Advisory Role - Exelixis
Research Funding - Sanofi
 
Daniel H. Shevrin
Speakers' Bureau - Bayer; Sanofi/Aventis
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen; Merck; Novartis; Pfizer; Sanofi; Tempus; Vividion Therapeutics
Research Funding - Bayer (Inst); Pfizer (Inst); Tempus (Inst)
 
Bridget F. Koontz
Consulting or Advisory Role - Blue Earth Diagnostics
Research Funding - Blue Earth Diagnostics; Janssen; Merck
Patents, Royalties, Other Intellectual Property - Demos Publishing
 
Evan Y. Yu
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Bayer; Clovis Oncology; Dendreon; Janssen; Merck; Myovant Sciences; Sanofi; Seagen
Research Funding - Bayer (Inst); Blue Earth Diagnostics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Volkan Beylergil
No Relationships to Disclose
 
Jonathan McConathy
Consulting or Advisory Role - AVID Radiopharmaceuticals; Blue Earth Diagnostics; GE Healthcare
Research Funding - Abbvie (I); Advanced Accelerator Applications (Inst); Blue Earth Diagnostics (Inst); ImaginAb (Inst); navidea (I)
 
Glenn Liu
Employment - AIQ Solutions
Leadership - AIQ Solutions
Stock and Other Ownership Interests - AIQ Solutions
Consulting or Advisory Role - Exelixis; Novartis; Tricon Pharmaceuticals
Research Funding - Johnson & Johnson (Inst); Madison Vaccines, Inc.; Novartis (Inst); Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
Travel, Accommodations, Expenses - AIQ Solutions; TRACON Pharma
 
David A. Mankoff
Stock and Other Ownership Interests - ImaginAb; Reflexion Medical; Trevarx Biomedical (I)
Consulting or Advisory Role - Philips Healthcare
Other Relationship - ImaginAb; Reflexion Medical
 
Terence Z. Wong
Honoraria - Wake Radiology
Consulting or Advisory Role - Lucerno Dynamics
 
Michael Anthony Carducci
Consulting or Advisory Role - Abbvie; Astellas Pharma; Foundation Medicine; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); eFFECTOR Therapeutics (Inst); EMD Serono (Inst); Gilead Sciences (Inst); pfizer (Inst)